Navigation Links
Carnegie Mellon's Philip LeDuc participates in think tank forums
Date:11/11/2008

PITTSBURGHCarnegie Mellon University's Philip R. LeDuc will join more than 70 of the brightest scientific researchers Nov. 12-15 at the National Academies Keck Futures Initiative on Complexity at the Beckman Conference Center in Irvine, Calif.

Invited participants will discuss the topic of complexity in areas spanning everything from neural function to social systems and achieving a sustainable future.

"This is a great opportunity for me to interact with professionals from a broad spectrum of fields and to exchange research ideas," said LeDuc, an associate professor in mechanical engineering with a courtesy appointment in biomedical engineering and biological sciences.

The event, a joint venture between the National Academy of Science, the National Academy of Engineering and the Institute of Medicine, brings together researchers from a variety of academic disciplines, including engineering, computer science, physics, biology and chemistry.

In early November, LeDuc also was invited to attend and speak to researchers at a think tank event for the National Institute of Health's National Cancer Center about how systems such as cells and cancerous tissues in the human body may operate in a similar manner to a robotic system. These two events are focused on generating out-of-the-box thinking and approaches for taking on some of the biggest challenges in the future.

"There is going to be a lot of debate about how we will be able to approach grand challenges through non-traditional approaches. Carnegie Mellon has long been an innovator in bridging disciplines toward these ends, and this is a potential example of how approaches that were developed for systems such as robots could contribute to areas such as biology and medicine," said LeDuc, a recipient of the 2005 Beckman Award for leading-edge research in the biological and chemical sciences even though he is a mechanical engineer.

LeDuc is building tools that merge engineering technology with both scientific and commercial applications. He is using cell and molecular inspired approaches for developing new technology, probing cell and molecular biomechanics for understanding diseases, and pursuing computational methods to understand molecular behavior.

"By better understanding how cells communicate and how they use inherent systems such as feedback and redundancy to keep the cell in operation, we can begin to harness the cell's natural abilities, which may translate into exciting future technologies or approaches to fight diseases," LeDuc said.

His other accolades include winning the prestigious National Science Foundation Career Award, publishing a number of research articles in prestigious journals like Nature, Nature Nanotechnology and NanoLetters, and being a co-founder and head of missionary work in Ghana, Africa.

Prior to coming to Carnegie Mellon in 2002, LeDuc was a fellow at Harvard Medical School and Children's Hospital, where he spent time building multidisciplinary efforts between groups in biology, engineering, physics and chemistry.


'/>"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
Source:Eurekalert

Related biology news :

1. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
4. Carnegie Mellon, Pitt Team to study psychosocial stress
5. Mellon awards Carnegie Grant for Ecological Monitoring in South Africa
6. Carnegie Mellon researchers to develop new drug delivery system
7. Carnegie Mellon students win contest
8. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
9. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
10. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
11. Carnegie Mellon receives $1.85 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: